Adlai Nortye Ltd. (ANL)
NASDAQ: ANL · Real-Time Price · USD
7.95
-0.41 (-4.90%)
At close: Mar 13, 2026, 4:00 PM EDT
7.91
-0.04 (-0.50%)
After-hours: Mar 13, 2026, 6:06 PM EDT
Adlai Nortye Market Cap
Adlai Nortye has a market cap or net worth of $880.07 million as of March 13, 2026. Its market cap has increased by 969.51% in one year.
Market Cap
880.07M
Enterprise Value
883.81M
1-Year Change
969.51%
Ranking
Category
Stock Price
$7.95
Market Cap Chart
Since the IPO on September 29, 2023, Adlai Nortye's market cap has increased from $553.50M to $880.07M, an increase of 59.00%. That is a compound annual growth rate of 20.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 293.36M | 459.86% |
| Dec 31, 2025 | 52.40M | -47.12% |
| Dec 31, 2024 | 99.08M | -70.13% |
| Dec 29, 2023 | 331.73M | -40.07% |
| Sep 29, 2023 | 553.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 329.22M |
| XOMA Royalty | 320.04M |
| Rezolute | 313.69M |
| Avalo Therapeutics | 309.35M |
| Cabaletta Bio | 307.09M |
| Palisade Bio | 302.48M |
| Puma Biotechnology | 299.15M |
| AC Immune | 296.83M |